实验研究
ENGLISH ABSTRACT
TLR2单克隆抗体对大鼠角膜移植术后植片存活的保护作用
白浪
郑艳华
梁伟怡
作者及单位信息
·
DOI: 10.3760/cma.j.issn.2095-0160.2015.10.005
Protective role of anti-TLR2 monoclonal antibody to corneal graft survival after allograft corneal transplantation in rats
Bai Lang
Zheng Yanhua
Liang Weiyi
Authors Info & Affiliations
Bai Lang
Department of Ophthalmology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
Zheng Yanhua
Liang Weiyi
·
DOI: 10.3760/cma.j.issn.2095-0160.2015.10.005
425
5
0
0
0
0
PDF下载
APP内阅读
摘要

背景Toll样受体2(TLR2)在移植免疫相关疾病中的作用越来越受到关注,阻断TLR2对心脏和肾脏移植物的保护作用已有研究报道,但TLR2是否具有抑制角膜移植排斥反应的作用尚未证实。

目的观察TLR2单克隆抗体对同种异体大鼠角膜移植术后植片存活情况的影响。

方法取24只SPF级雌性Wistar大鼠作为受体,12只SPF级SD大鼠作为供体,体质量均为180~220 g。采用同种异体角膜移植的方法在Wistar大鼠右眼实施穿透角膜移植术,制备大鼠角膜移植模型。采用随机数字表法将模型眼分为单纯模型组和TLR2单克隆抗体组,TLR2单克隆抗体组分别于术后0、2、4、6、8 d球结膜下注射TLR2单克隆抗体15 μg/30 μl,单纯模型组大鼠同法注射等容量生理盐水。术后每日于裂隙灯显微镜下观察各组大鼠角膜植片水肿程度、透明度和新生血管形成情况,参照Holland等的评分标准对排斥反应指数(RI)进行评分;分别于术后第9天、第15天收集各组3只大鼠角膜组织,另取3只正常Wistar大鼠眼球作为正常对照,行常规组织病理学检查。各组取6只大鼠用于生存分析观察。

结果术后1~4 d,裂隙灯显微镜下2个组角膜均轻度水肿,术后9~14 d,单纯模型组大鼠角膜植片布满新生血管,可见植片水肿、混浊,而TLR2单克隆抗体组大鼠植片至术后第15天开始混浊。术后5、9、15 d,单纯模型组大鼠RI评分均明显高于TLR2单克隆抗体组,差异均有统计学意义( t=4.183、4.954、13.506,均 P<0.05);TLR2单克隆抗体组角膜植存活时间为15.5 d,95%可信区间( CI)为14.9~16.1,单纯模型组角膜植片存活时间为9.5 d,95% CI为8.7~10.3,2个组间差异有统计学意义( Z=12.728, P=0.001)。角膜组织病理学检查显示,单纯模型组大鼠角膜基质层水肿明显,角膜组织中可见大量炎性细胞浸润和新生血管管腔形成,而在TLR2单克隆抗体组中仅见少量炎性细胞和新生血管。

结论TLR2单克隆抗体能减轻角膜移植术后的炎症反应,延长角膜植片的存活时间。

Toll样受体2;单克隆抗体/用法和用量;穿透角膜移植/病理;植片排斥/病理;植片存活/药物作用;动物模型
ABSTRACT

BackgroundThe effects of Toll-like receptor 2 (TLR2) in grafting-related immune diseases have attracted more and more attention.Blocking TLR2 signal pathway can extend the survival time of heart and kidney grafts.However, the effects of anti-TLR2 monoclonal antibody on corneal graft have not been confirmed.

ObjectiveThis study was to investigate the influence of anti-TLR2 monoclonal antibody on corneal graft survival in the rats received penetrating keratoplasty (PKP).

MethodsAllograft corneal transplantation was performed on the right eyes of 24 SPF female Wistar rats to establish PKP models, with 12 SD rats as donors.The model eyes were randomized into the TLR2 monoclonal antibody group and the model group.Anti-TLR2 monoclonal antibody of 15 μg/30 μl was subconjunctivally injected on day 0, 2, 4, 6 and 8 following the modeling in the TLR2 monoclonal antibody group, and equal amount of normal saline was injected in the same way in the model group.The edema, transparency and neovascularization were observed under the slit lamp microscope after surgery, and rejection index (RI) was scored based on the criteria of Holland.Corneal tissue sections of the rats were prepared for the histopathological examination on day 9 and 15 after operation.The research protocol was approved by the Southern Medical University Ethics Committee.

ResultsMild corneal edema was found in the two groups 1-4 days after operation.A lot of new blood vessels, edema and opacification of corneas were seen in the model group 9-14 days after operation, but in the TLR2 monoclonal antibody group, corneal opacification was found 15 days after operation.The RI scores were significantly higher in the model group than those in the TLR2 monoclonal antibody group 5, 9, 15 days after operation ( t=4.183, 4.954, 13.506; all at P<0.05). The survival time in the TLR2 monoclonal antibody group was 15.5 days, with the 95% confidence interval ( CI) 14.9-16.1; while that in the model group was 9.5 days, with the 95% CI 8.7-10.3, showing a significant difference between the two groups ( Z=12.728, P=0.001). The corneal histopathological examination revealed that corneal stromal edema, infiltration of inflammatory cells and vascular lumen were more prominent 9 and 15 days after operation in the model group than those in the TLR2 monoclonal antibody group.

ConclusionsAnti-TLR2 monoclonal antibody can inhibit inflammatory response after allograft corneal transplantation and therefore extend the survival time of graft in rats.

Toll-like receptor 2;Antibodies, monoclonal/administration & dosage;Keratoplasty, penetrating/pathology;Graft rejection/pathology;Graft survival /drug effects;Disease models, animal
Bai Lang, Email: mocdef.6ab21yfsgnaliab
引用本文

白浪,郑艳华,梁伟怡. TLR2单克隆抗体对大鼠角膜移植术后植片存活的保护作用[J]. 中华实验眼科杂志,2015,33(10):887-891.

DOI:10.3760/cma.j.issn.2095-0160.2015.10.005

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
由于角膜组织具有不含血管和淋巴管及存在前房相关免疫偏离的特点,角膜处于相对免疫赦免状态,使得角膜移植的成功率高于其他组织器官移植。尽管如此,角膜移植排斥仍是导致角膜移植失败的主要原因 [ 1 ]。角膜移植术后免疫排斥反应是一个多因素参与、极其复杂的过程 [ 2 ]。供体植片移植后随着抗原的递呈,激活CD4 T细胞,促使辅助性T细胞1分化,分泌白细胞介素-2、γ干扰素和肿瘤坏死因子-α等,介导破坏性的迟发性超敏反应,在角膜移植排斥反应中起主导作用 [ 3 , 4 ]。最新研究表明,先天免疫系统在角膜移植排斥反应中也起着重要作用 [ 5 ]。Toll样受体(Toll-like receptors,TLRs)是连接天然免疫与获得性免疫的桥梁,其中TLR2是目前已克隆的人类TLRs家族中表达范围最广、识别病原微生物及其产物种类最多的分子。近年来,TLR2在移植免疫相关疾病中的作用越来越受到关注,阻断TLR2对心脏和肾脏移植物的保护作用已有研究报道 [ 6 , 7 ]。我们前期的研究也表明,TLR2单克隆抗体能降低角膜移植术后植片中TLR2及其下游信号分子髓样分化因子88(myeloid differentiation primary response protein 88,MyD88)的表达,认为TLR2/MyD88信号系统参与了角膜移植排斥反应 [ 8 ],但TLR2单克隆抗体能否延长角膜移植排斥反应后植片的存活时间尚不清楚。本研究中建立同种异体角膜移植大鼠模型,并利用TLR2单克隆抗体进行干预,观察角膜植片排斥反应的发生和发展,探讨TLR2单克隆抗体对角膜移植排斥反应的影响,为临床防治角膜移植排斥提供新的靶点。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
Waldock A , Cook SD . Corneal transplantation:how successful are we?[J]Br J Ophthalmol, 2000,84(8):813-815. doi: 10.1136/bjo.84.8.813 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
Ayliffe W , Alam Y , Bell EB ,et al. Prolongation of rat corneal graft survival by treatment with anti-CD4 monoclonal antibody[J]Br J Ophthalmol, 1992,76(10):602-606.
返回引文位置Google Scholar
百度学术
万方数据
[3]
宋静黄一飞同种异体角膜移植后角膜内皮细胞的特征表现及生物学意义[J]中华眼科杂志 201147(3):281-284. doi: 10.3760/cma.j.issn.0412-4081.2011.03.022 .
返回引文位置Google Scholar
百度学术
万方数据
[4]
Amirzargar A , Lessanpezeshki M , Fathi A ,et al. TH1/TH2 cytokine analysis in Iranian renal transplant recipients[J]Transplant Proc, 2005,37(7):2985-2987.
返回引文位置Google Scholar
百度学术
万方数据
[5]
Bai L , Lu XH , Sun FY ,et al. Blockade of toll-like receptor 2 expression and membrane translocation in rat corneal epithelial cells by glucocorticoid (TobraDex) after penetrating keratoplasty[J]Cornea, 2011,30(11):1253-1259. doi: 10.1097/ICO.0b013e318213f389 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
Arslan F , Smeets MB , O'Neill LA ,et al. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody[J]Circulation, 2010,121(1):80-90. doi: 10.1161/CIRCULATIONAHA.109.880187 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
Leemans JC , Stokman G , Claessen N ,et al. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney[J]J Clin Invest, 2005,115(10):2894-2903. doi: 10.1172/JCI22832 .
返回引文位置Google Scholar
百度学术
万方数据
[8]
郑艳华白浪梁伟怡TLR2/MyD88信号系统在大鼠角膜移植术后排斥反应中的作用[J]眼科新进展 201535(6):506-510. doi: 10.13389/j.cnki.rao.2015.0000 .
返回引文位置Google Scholar
百度学术
万方数据
[9]
Holland EJ , Chan CC , Wetzig RP ,et al. Clinical and immunohistologic studies of corneal rejection in the rat penetrating keratoplasty model[J]Cornea, 1991,10(5):374-380.
返回引文位置Google Scholar
百度学术
万方数据
[10]
Goldstein DR . Toll like receptors and acute allograft rejection[J]Transpl Immunol, 2006,17(1):11-15. doi: 10.1016/j.trim.2006.09.012 .
返回引文位置Google Scholar
百度学术
万方数据
[11]
陈辉星尹路彭承宏Toll-样受体在器官移植免疫中的作用[J]国际外科学杂志 200633(1):41-43. doi: 10.3760/cma.j.issn.1673-4203.2006.01.013 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
钟静静万岩岩刁昱文Toll样受体靶向药物的研究进展[J]生命科学 201527(4):439-444. doi: 10.13376/j.cbls/2015057 .
返回引文位置Google Scholar
百度学术
万方数据
[13]
Reilly M , Miller RM , Thomson MH ,et al. Randomized, double-blind, placebo-controlled, dose-escalating phase I, healthy subjects study of intravenous OPN-305, a humanized anti-TLR2 antibody[J]Clin Pharmacol Ther, 2013,94(5):593-600. doi: 10.1038/clpt .
返回引文位置Google Scholar
百度学术
万方数据
[14]
Wang S , Schmaderer C , Kiss E ,et al. Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling[J]Dis Model Mech, 2010,3(1-2):92-103. doi: 10.1242/dmm.003533 .
返回引文位置Google Scholar
百度学术
万方数据
[15]
Goldstein DR , Tesar BM , Akira S ,et al. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection[J]J Clin Invest, 2003,111(10):1571-1578. doi: 10.1172/JCI200317573 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
白浪陆晓和钟彦彦糖皮质激素对角膜移植术后大鼠角膜TLR2表达的影响[J]眼科研究 2009(11):1011-1014. doi: 10.3760/cma.j.issn.2095-016 0.2009.11.014 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
白浪,Email: mocdef.6ab21yfsgnaliab
B
国家自然科学基金项目 (81170887)
南方医科大学南方医院横向课题匹配基金项目 (G201202)
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号